Celyad Oncology SA (EBR:CYAD)

Celyad Oncology Revenue

In the year 2025, Celyad Oncology had annual revenue of 21.00K EUR, down -88.71%. Celyad Oncology had revenue of 14.00K in the half year ending June 30, 2025, a decrease of -68.18%.

• Revenue: 21.00K
• Revenue Growth: -88.71%
• P/S Ratio: 690.61
• Revenue / Employee: 4.20K
• Employees: 19
• Market Cap: 14.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	21.00K	-165.00K	-88.71%
Dec 31, 2024	186.00K	84.00K	82.35%
Dec 31, 2023	102.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-